Summary
Human galanin was recently isolated and sequenced and was found to differ from porcine galanin, hitherto used for studies in humans, in several important respects. We therefore synthesized and purified human galanin and infused it i.v. at a rate of 74 pmol · kg−1· min−1 into six healthy volunteers for 60 min during a hyperglycaemic clamp. The clamp was achieved by i. v. infusion of glucose at a rate which in a control experiment had been demonstrated to maintain the plasma glucose level at 12–13 mmol/l for 90 min. Galanin concentrations reached a plateau of approximately 1500 pmol/l throughout the infusion as opposed to pre-infusion and control levels of 20–30 pmol/l. The glucose levels obtained in the two experiments were indistinguishable. Plasma levels of C-peptide and insulin increased significantly in both experiments and the dynamic concentration curves were almost identical. Glucagon concentrations in plasma decreased significantly and similarly. Growth hormone levels, however, increased eight-fold during galanin infusions. Galanin was eliminated from plasma with a half-life of 3.7±0.4 min, similar to that of porcine galanin. It is concluded that human galanin powerfully stimulates growth hormone secretion in man, but has no effect on pancreatic endocrine secretion or glucose metabolism in the concentrations obtained in this study.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tatemoto K, Rökaeus Å, Jörnvall H, McDonald TJ, Mutt V (1983) Galanin — a novel biologically active peptide from porcine intestine. FEBS Lett 164: 124–128
Rökaeus Å (1987) Galanin: a newly isolated biologically active neuropeptide. Trends Neurosci 10: 158–164
Dunning BE, Ahren B, Veith RC, Bötcher G, Sundler F, Taborsky GJ (1986) Galanin: a novel pancreatic neuropeptide. Am J Physiol 251:E127-E133
Shimosegawa T, Moriisumi S, Koizumi M, Kashimura J, Yanaihara N, Toyota T (1992) Immunohistochemical demonstration of galanin like immunoreactive nerves in the human pancreas. Gastroenterology 102: 263–271
Dunning BE, Taborsky GJ (1988) Galanin — sympathetic neurotransmittter in endocrine pancreas·? Diabetes 37: 1157–1162
Amiranoff B, Servin AL, Rouyer-Fessard C, Couvineau A, Tatemoto K, Laburthe M (1987) Galanin receptors in a hamster pancreatic β-cell tumor: identification and molecular characterization. Endocrinology 121: 284–289
Homaidan FR, Sharp GWG, Nowak LM (1991) Galanin inhibits a dihydropyridine-sensitive Ca2+ current in the RINm5 f cell line. Proc Natl Acad Sci USA 88: 8744–8748
Lindskog S, Ahrén B (1992) Studies on the mechanism by which galanin inhibits insulin secretion in islets. Eur J Pharmacol 205: 21–27
Gilbey SG, Stephenson J, O'Halloran DJ, Burrin JM, Bloom SR (1989) High-dose porcine galanin infusion and effect on intravenous glucose tolerance in humans. Diabetes 38: 1114–1116
Messel T, Harling H, Böttcher G, Johnsen AH, Holst JJ (1990) Galanin in the porcine pancreas. Regul Pept 28: 161–176
Bersani M, Johnsen AH, Højrup P, Dunning BE, Andreasen JJ, Holst JJ (1991) Human galanin: primary structure and identification of two molecular forms. FEBS Lett 283: 189–194
Tam JP, Heath WF, Merrifield RB (1983) SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J Am Chem Soc 105: 6442–6446
Ørskov H, Thomsen HE, Yde H (1968) Wick-chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 219: 193–195
Albano JDM, Ekins RP, Maritz G, Turner RC (1972) A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) 70: 487–509
Holst JJ (1980) Evidence that glicentin contains the entire sequence of glucagon. Biochem J 187: 337–343
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Holst JJ, Bersani M (1991) Assays for the peptide products of somatostatin gene expression. Meth Neurosci 5: 3–21
Goldstein A, Aronow L, Kalman SM (1974) Principles of drug action: the basis of pharmacology. Wiley, New York, p 323
Holst JJ (1992) Role of classical and peptidergic neurotransmitters in insulin secretion. In: Flatt PR (ed) Nutrient regulation of insulin secretion. Portland Press, London, pp 23–40
Ahren B, Böttcher G, Kowalyk S, Dunning BE, Sundler F, Taborsky GJ (1990) Galanin is co-localized with noradrenaline and neuropeptide Y in dog pancreas and celiac ganglion. Cell Tiss Res 261: 49–58
Dunning BE, Taborsky GJ (1989) Galanin release during pancreatic nerve stimulation is sufficient to influence islet function. Am J Physiol 256:E191-E198
Ahren B (1990) Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man. Acta Endocrinol (Copenh) 123: 591–597
Ahren B, Ar'Rajab A, Böttcher G, Sundler F, Dunning BE (1991) Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets. Cell Tiss Res 164: 263–267
Bauer FE, Venetikou M, Burrin JM, Ginsberg L, MacKay DJ, Bloom SR (1986) Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet II: 192–194
Hermansen K (1988) Effects of galanin on the release of insulin, glucagon and somatostatin from the isolated, perfused dog pancreas. Acta Endocrinol (Copenh) 119: 91–98
Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR (1989) Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 97: 260–264
McKnight GL, Karlsen AE, Kowalyk S, et al (1992) Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RUST cells. Diabetes 41: 82–87
Rattan S (1991) Role of galanin in the gut. Gastroenterology 100: 1762–1768
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holst, J.J., Bersani, M., Hvidberg, A. et al. On the effects of human galanin in man. Diabetologia 36, 653–657 (1993). https://doi.org/10.1007/BF00404076
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404076